Bone density recovery after depot medroxyprogesterone acetate injectable contraception use

References

1. • Westhoff C.
   Depot-medroxyprogesterone acetate injection (Depo-Provera��): a highly effective contraceptive option with proven long-term safety.
   Contraception. 2003; 68: 75-87
   View in Article

   • Google Scholar
2. • Cromer B.A.
   Bone mineral density in adolescent and young adult women on injectable or oral contraception.
   Curr Opin Obstet Gynecol. 2003; 15: 353-357
   View in Article

   • Google Scholar
3. • Chiou C.F.
   • Trussell J.
   • Reyes E.
   • et al.
   Economic analysis of contraceptives for women.
   Contraception. 2003; 68: 3-10
   View in Article

   • Google Scholar
4. • Kaunitz A.M.
   Depo-Provera's black box: time to reconsider?.
   Contraception. 2005; 72: 165-167
   View in Article

   • Google Scholar
5. • Mosher W.D.
   • Martinez G.M.
   • Chandra A.
   • Abma J.C.
   • Willson S.J.
   Use of contraception and use of family planning services in the United States: 1982-2002. Advance data from vital and health statistics; No. 350.
   National Center for Health Statistics, Hyattsville, MD2004
   View in Article

   • Google Scholar
6. • Shelton J.
   FDA Approval of SC Depo-Provera. Center for Communication Programs Pearl of the Week.
   The Johns Hopkins University, Baltimore2006 (www.jhuccp.org/pearls. Accessed August 29)
   View in Article

   • Google Scholar
7. • Jain J.
   • Jakimiuk A.J.
   • Bode F.R.
   • Ross D.
   • Kaunitz A.M.
   Contraceptive efficacy and safety of DMPA-SC.
   Contraception. 2004; 70: 269-275
   View in Article

   • Google Scholar
8. Depo-Provera [physician information].
   Pfizer Inc, New York2004
   View in Article

   • Google Scholar
9. • Mishell Jr., D.R.
   Pharmacokinetics of depot medroxyprogesterone acetate contraception.
   J Reprod Med. 1996; 41: 381-390
   View in Article

   • Google Scholar
10. • Hergenroeder A.C.
    Bone mineralization, hypothalamic amenorrhea, and sex steroid therapy in female adolescents and young adults.
    J Pediatr. 1995; 126: 683-689
    View in Article

    • Google Scholar
11. • Gbolade B.A.
    Depo-Provera and bone density.
    J Fam Plann Reprod Health Care. 2002; 28: 7-11
    View in Article

    • Google Scholar
12. • Curtis K.M.
    • Martins S.L.
    Progestogen-only contraception and bone mineral density: a systematic review.
    Contraception. 2006; 73: 470-487
    View in Article

    • Google Scholar
13. • Tang O.S.
    • Tang G.
    • Yip P.
    • Li B.
    • Fan S.
    Long-term depot-medroxyprogesterone acetate and bone mineral density.
    Contraception. 1999; 59: 25-29
    View in Article

    • Google Scholar
14. • Scholes D.
    • Lacroix A.Z.
    • Ichikawa L.E.
    • Barlow W.E.
    • Ott S.M.
    Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception.
    Arch Pediatr Adolesc Med. 2005; 159: 139-144
    View in Article

    • Google Scholar
15. • Scholes D.
    • Lacroix A.Z.
    • Ichikawa L.E.
    • Barlow W.E.
    • Ott S.M.
    Injectable hormone contraception and bone density: results from a prospective study.
    Epidemiology. 2002; 13: 581-587
    View in Article

    • Google Scholar
16. • Scholes D.
    • Lacroix A.Z.
    • Ott S.M.
    • Ichikawa L.E.
    • Barlow W.E.
    Bone mineral density in women using depot medroxyprogesterone acetate for contraception.
    Obstet Gynecol. 1999; 93: 233-238
    View in Article

    • Google Scholar
17. • Paiva L.C.
    • Pinto-Neto A.M.
    • Faundes A.
    Bone density among long-term users of medroxyprogesterone acetate as a contraceptive.
    Contraception. 1998; 58: 351-355
    View in Article

    • Google Scholar
18. • Lara-Torre E.
    • Edwards C.P.
    • Perlman S.
    • Hertweck S.P.
    Bone mineral density in adolescent females using depot medroxyprogesterone acetate.
    J Pediatr Adolesc Gynecol. 2004; 17: 17-21
    View in Article

    • Google Scholar
19. • Gbolade B.
    • Ellis S.
    • Murby B.
    • Randall S.
    • Kirkman R.
    Bone density in long term users of depot medroxyprogesterone acetate.
    Br J Obstet Gynaecol. 1998; 105: 790-794
    View in Article

    • Google Scholar
20. • Cromer B.A.
    • Lazebnik R.
    • Rome E.
    • Bonny A.
    • Ziegler J.
    • Debanne S.M.
    Double-blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception.
    Am J Obstet Gynecol. 2005; 192: 42-47
    View in Article

    • Google Scholar
21. • Cromer B.A.
    • Stager M.
    • Bonny A.
    • et al.
    Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls.
    J Adolesc Health. 2004; 35: 434-441
    View in Article

    • Google Scholar
22. • Cromer B.A.
    • Blair J.M.
    • Mahan J.D.
    • Zibners L.
    • Naumovski Z.
    A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
    J Pediatr. 1996; 129: 671-676
    View in Article

    • Google Scholar
23. • Clark M.K.
    • Sowers M.F.R.
    • Nichols S.
    • Levy B.
    Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate.
    Fertil Steril. 2004; 82: 1580-1586
    View in Article

    • Google Scholar
24. • Berenson A.B.
    • Radecki C.M.
    • Grady J.J.
    • Rickert V.I.
    • Thomas A.
    A prospective, controlled study of the effects of hormonal contraception on bone mineral density.
    Obstet Gynecol. 2001; 98: 576-582
    View in Article

    • Google Scholar
25. • Bahamondes L.
    • Perrotti M.
    • Castro S.
    • Faundes D.
    • Petta C.
    • Bedone A.
    Forearm bone density in users of Depo-Provera as a contraceptive method.
    Fertil Steril. 1999; 71: 849-852
    View in Article

    • Google Scholar
26. • Cundy T.
    • Evans M.
    • Roberts H.
    • Wattie D.
    • Ames R.
    • Reid I.R.
    Bone density in women receiving depot medroxyprogesterone acetate for contraception.
    BMJ. 1991; 303: 13-16
    View in Article

    • Google Scholar
27. • Cundy T.
    • Cornish J.
    • Roberts H.
    • Elder H.
    • Reid I.R.
    Spinal bone density in women using depot medroxyprogesterone contraception.
    Obstet Gynecol. 1998; 92: 569-573
    View in Article

    • Google Scholar
28. • Cundy T.
    • Cornish J.
    • Roberts H.
    • Reid I.R.
    Menopausal bone loss in long-term users of depot medroxyprogesterone acetate contraception.
    Am J Obstet Gynecol. 2002; 186: 978-983
    View in Article

    • Google Scholar
29. • Cundy T.
    • Ames R.
    • Horne A.
    • Roberts H.
    • Gamble G.
    • Reid I.R.
    A randomized controlled trial of estrogen replacement therapy in long-term users of depot medroxyprogesterone acetate.
    J Clin Endocrinol Metab. 2003; 88: 78-81
    View in Article

    • Google Scholar
30. • Berenson A.B.
    • Breitkopf C.R.
    • Grady J.J.
    • Rickert V.I.
    • Thomas A.
    Effects of hormonal contraception on bone mineral density after 24 months of use.
    Obstet Gynecol. 2004; 103: 899-906
    View in Article

    • Google Scholar
31. • Kaunitz A.M.
    • Miller P.D.
    • Rice V.M.
    • Ross D.
    • McClung M.R.
    Bone mineral density in women aged 25���35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation.
    Contraception. 2006; 74: 90-99
    View in Article

    • Google Scholar
32. • Naessen T.
    • Olsson S.E.
    • Gudmundson J.
    Differential effects on bone density of progestogen-only methods for contraception in premenopausal women.
    Contraception. 1995; 52: 35-39
    View in Article

    • Google Scholar
33. • Tang O.S.
    • Tang G.
    • Yip P.S.
    • Li B.
    Further evaluation on long-term depot-medroxyprogesterone acetate use and bone mineral density: a longitudinal cohort study.
    Contraception. 2000; 62: 161-164
    View in Article

    • Google Scholar
34. • Virutamasen P.
    • Wangsuphachart S.
    • Reinprayoon D.
    • Kriengsinyot R.
    • Leepipatpaiboon S.
    • Gua C.
    Trabecular bone in long-term depot-medroxyprogesterone acetate users.
    Asia Oceania J Obstet Gynaecol. 1994; 20: 269-274
    View in Article

    • Google Scholar
35. • Taneepanichskul S.
    • Intaraprasert S.
    • Theppisai U.
    • Chaturachinda K.
    Bone mineral density in long-term depot medroxyprogesterone acetate acceptors.
    Contraception. 1997; 56: 1-3
    View in Article

    • Google Scholar
36. • Taneepanichskul S.
    • Intaraprasert S.
    • Theppisai U.
    • Chaturachinda K.
    Bone mineral density during long-term treatment with Norplant implants and depot medroxyprogesterone acetate. A cross-sectional study of Thai women.
    Contraception. 1997; 56: 153-155
    View in Article

    • Google Scholar
37. • Orr-Walker B.J.
    • Evans M.C.
    • Ames R.W.
    • Clearwater J.M.
    • Cundy T.
    • Reid I.R.
    The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women.
    Clin Endocrinol (Oxf). 1998; 49: 615-618
    View in Article

    • Google Scholar
38. • Merki-Feld G.S.
    • Neff M.
    • Keller P.J.
    A prospective study on the effects of depot medroxyprogesterone acetate on trabecular and cortical bone after attainment of peak bone mass.
    BJOG. 2000; 107: 863-869
    View in Article

    • Google Scholar
39. • Merki-Feld G.S.
    • Neff M.
    • Keller P.J.
    A 2-year prospective study on the effects of depot medroxyprogesterone acetate on bone mass-response to estrogen and calcium therapy in individual users.
    Contraception. 2003; 67: 79-86
    View in Article

    • Google Scholar
40. • Petitti D.B.
    • Piaggio G.
    • Mehta S.
    • Cravioto M.C.
    • Meirik O.
    Steroid hormone contraception and bone mineral density: a cross-sectional study in an international population.
    Obstet Gynecol. 2000; 95: 736-744
    View in Article

    • Google Scholar
41. • Busen N.H.
    • Britt R.B.
    • Rianon N.
    Bone mineral density in a cohort of adolescent women using depot medroxyprogesterone acetate for one to two years.
    J Adolesc Health. 2003; 32: 257-259
    View in Article

    • Google Scholar
42. • Beksinska M.E.
    • Smit J.A.
    • Kleinschmidt I.
    • Farley T.M.
    • Mbatha F.
    Bone mineral density in women aged 40���49 years using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraceptives for contraception.
    Contraception. 2005; 71: 170-175
    View in Article

    • Google Scholar
43. • Scholes D.
    • Lacroix A.Z.
    • Ichikawa L.E.
    • Barlow W.E.
    • Ott S.M.
    The association between depot medroxyprogesterone acetate contraception and bone mineral density in adolescent women.
    Contraception. 2004; 69: 99-104
    View in Article

    • Google Scholar
44. • Tharnprisarn W.
    • Taneepanichskul S.
    Bone mineral density in adolescent and young Thai girls receiving oral contraceptives compared with depot medroxyprogesterone acetate: a cross-sectional study in young Thai women.
    Contraception. 2002; 66: 101-103
    View in Article

    • Google Scholar
45. • Wanichsetakul P.
    • Kamudhamas A.
    • Watanaruangkovit P.
    • Siripakarn Y.
    • Visutakul P.
    Bone mineral density at various anatomic bone sites in women receiving combined oral contraceptives and depot-medroxyprogesterone acetate for contraception.
    Contraception. 2002; 65: 407-410
    View in Article

    • Google Scholar
46. • Schlaff W.D.
    • Carson S.A.
    • Luciano A.
    • Ross D.
    • Bergqvist A.
    Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain.
    Fertil Steril. 2006; 85: 314-325
    View in Article

    • Google Scholar
47. • Ryan P.J.
    • Singh S.P.
    • Guillebaud J.
    Depot medroxyprogesterone and bone mineral density.
    J Fam Plann Reprod Health Care. 2002; 28: 12-15
    View in Article

    • Google Scholar
48. • Rome E.
    • Ziegler J.
    • Secic M.
    • et al.
    Bone biochemical markers in adolescent girls using either depot medroxyprogesterone acetate or an oral contraceptive.
    J Pediatr Adolesc Gynecol. 2004; 17: 373-377
    View in Article

    • Google Scholar
49. • Perrotti M.
    • Bahamondes L.
    • Petta C.
    • Castro S.
    Forearm bone density in long-term users of oral combined contraceptives and depot medroxyprogesterone acetate.
    Fertil Steril. 2001; 76: 469-473
    View in Article

    • Google Scholar
50. • Crosignani P.G.
    • Luciano A.
    • Ray A.
    • Bergqvist A.
    Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain.
    Hum Reprod. 2006; 21: 248-256
    View in Article

    • Google Scholar
51. • Shaarawy M.
    • El Mallah S.Y.
    • Seoudi S.
    • Hassan M.
    • Mohsen I.A.
    Effects of the long-term use of depot medroxyprogesterone acetate as hormonal contraceptive on bone mineral density and biochemical markers of bone remodeling.
    Contraception. 2006; 74: 297-302
    View in Article

    • Google Scholar
52. • Clark M.K.
    • Sowers M.
    • Levy B.
    • Nichols S.
    Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetate.
    Fertil Steril. 2006;
    View in Article

    • Google Scholar
53. • Cundy T.
    • Cornish J.
    • Evans M.C.
    • Roberts H.
    • Reid I.R.
    Recovery of bone density in women who stop using medroxyprogesterone acetate.
    BMJ. 1994; 308: 247-248
    View in Article

    • Google Scholar
54. • Albertazzi P.
    • Bottazzi M.
    • Steel S.A.
    Bone mineral density and depot medroxyprogesterone acetate.
    Contraception. 2006; 73: 577-583
    View in Article

    • Google Scholar
55. • Cundy T.
    • Ames R.
    • Clearwater J.
    • et al.
    Bone density in long-term DMPA users: a double-blind randomised controlled trial of estrogen replacement therapy.
    J Bone Miner Res. 2001; 16 (Abstract F390): S221
    View in Article

    • Google Scholar
56. • World Health Organization
    WHO Statement on Hormonal Contraception and Bone Health. WHO Epidemiological Record No. 35.
    World Health Organization, Geneva, Switzerland2005
    View in Article

    • Google Scholar
57. • McClung M.R.
    The relationship between bone mineral density and fracture risk.
    Curr Osteoporos Rep. 2005; 3: 57-63
    View in Article

    • Google Scholar
58. • Kanis J.A.
    • Borgstrom F.
    • De Laet C.
    • et al.
    Assessment of fracture risk.
    Osteoporos Int. 2005; 16: 581-589
    View in Article

    • Google Scholar
59. • Kanis J.A.
    • Johnell O.
    • Oden A.
    • Dawson A.
    • De Laet C.
    • Jonsson B.
    Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds.
    Osteoporos Int. 2001; 12: 989-995
    View in Article

    • Google Scholar
60. • Black A.
    Canadian contraception consensus���update on depot medroxyprogesterone acetate (DMPA).
    J Obstet Gynaecol Can. 2006; 28: 305-313
    View in Article

    • Google Scholar
61. • Banks E.
    • Berrington A.
    • Casabonne D.
    Overview of the relationship between use of progestogen-only contraceptives and bone mineral density.
    BJOG. 2001; 108: 1214-1221
    View in Article

    • Google Scholar
62. • Kalkwarf H.J.
    • Specker B.L.
    Bone mineral loss during lactation and recovery after weaning.
    Obstet Gynecol. 1995; 86: 26-32
    View in Article

    • Google Scholar
63. • Polatti F.
    • Capuzzo E.
    • Viazzo F.
    • Colleoni R.
    • Klersy C.
    Bone mineral changes during and after lactation.
    Obstet Gynecol. 1999; 94: 52-56
    View in Article

    • Google Scholar
64. • Karlsson C.
    • Obrant K.J.
    • Karlsson M.
    Pregnancy and lactation confer reversible bone loss in humans.
    Osteoporos Int. 2001; 12: 828-834
    View in Article

    • Google Scholar
65. • Chantry C.J.
    • Auinger P.
    • Byrd R.S.
    Lactation among adolescent mothers and subsequent bone mineral density.
    Arch Pediatr Adolesc Med. 2004; 158: 650-656
    View in Article

    • Google Scholar
66. • Carranza-Lira S.
    • Mera J.P.
    Influence of number of pregnancies and total breast-feeding time on bone mineral density.
    Int J Fertil. 2002; 47: 169-171
    View in Article

    • Google Scholar
67. • Prentice A.
    • Jarjou L.M.
    • Cole T.J.
    • Stirling D.M.
    • Dibba B.
    • Fairweather-Tait S.
    Calcium requirements of lactating Gambian mothers: effects of a calcium supplement on breast-milk calcium concentration, maternal bone mineral content, and urinary calcium excretion.
    Am J Clin Nutr. 1995; 62: 58-67
    View in Article

    • Google Scholar
68. • Ritchie L.D.
    • Fung E.B.
    • Halloran B.P.
    • et al.
    A longitudinal study of calcium homeostasis during human pregnancy and lactation and after resumption of menses.
    Am J Clin Nutr. 1998; 67: 693-701
    View in Article

    • Google Scholar
69. • Krebs N.F.
    • Reidinger C.J.
    • Robertson A.D.
    • Brenner M.
    Bone mineral density changes during lactation: maternal, dietary, and biochemical correlates.
    Am J Clin Nutr. 1997; 65: 1738-1746
    View in Article

    • Google Scholar
70. • Lopez J.M.
    • Gonzalez G.
    • Reyes V.
    • Campino C.
    • Diaz S.
    Bone turnover and density in healthy women during breastfeeding and after weaning.
    Osteoporos Int. 1996; 6: 153-159
    View in Article

    • Google Scholar
71. • Sowers M.
    • Corton G.
    • Shapiro B.
    • et al.
    Changes in bone density with lactation.
    JAMA. 1993; 269: 3130-3135
    View in Article

    • Google Scholar
72. • Paton L.M.
    • Alexander J.L.
    • Nowson C.A.
    • Frame M.G.
    • Kaymakci B.
    • Wark J.D.
    Pregnancy and lactation have no long-term deleterious effect on measures of bone mineral in healthy women: a twin study.
    Am J Clin Nutr. 2003; 77: 707-714
    View in Article

    • Google Scholar
73. • Henderson III, P.H.
    • Sowers M.F.
    • Kutzko K.E.
    • Jannausch M.L.
    Bone mineral density in grand multiparous women with extended lactation.
    Am J Obstet Gynecol. 2000; 182: 1371-1377
    View in Article

    • Google Scholar
74. • Kolthoff N.
    • Eiken P.
    • Kristensen B.
    • Nielsen S.P.
    Bone mineral changes during pregnancy and lactation: a longitudinal cohort study.
    Clin Sci (Lond). 1998; 94: 405-412
    View in Article

    • Google Scholar
75. • Hayslip C.C.
    • Klein T.A.
    • Wray H.L.
    • Duncan W.E.
    The effects of lactation on bone mineral content in healthy postpartum women.
    Obstet Gynecol. 1989; 73: 588-592
    View in Article

    • Google Scholar
76. • More C.
    • Bettembuk P.
    • Bhattoa H.P.
    • Balogh A.
    The effects of pregnancy and lactation on bone mineral density.
    Osteoporos Int. 2001; 12: 732-737
    View in Article

    • Google Scholar
77. • Holmberg-Marttila D.
    • Sievanen H.
    Prevalence of bone mineral changes during postpartum amenorrhea and after resumption of menstruation.
    Am J Obstet Gynecol. 1999; 180: 537-538
    View in Article

    • Google Scholar
78. • Kalkwarf H.J.
    Lactation and maternal bone health.
    Adv Exp Med Biol. 2004; 554: 101-114
    View in Article

    • Google Scholar
79. • Honda A.
    • Kurabayashi T.
    • Yahata T.
    • Tomita M.
    • Takakuwa K.
    • Tanaka K.
    Lumbar bone mineral density changes during pregnancy and lactation.
    Int J Gynecol Obstet. 1998; 63: 253-258
    View in Article

    • Google Scholar
80. • Hillier T.A.
    • Rizzo J.H.
    • Pedula K.L.
    • et al.
    Nulliparity and fracture risk in older women: the study of osteoporotic fractures.
    J Bone Miner Res. 2003; 18: 893-899
    View in Article

    • Google Scholar
81. • Michaelsson K.
    • Baron J.A.
    • Farahmand B.Y.
    • Ljunghall S.
    Influence of parity and lactation on hip fracture risk.
    Am J Epidemiol. 2001; 153: 1166-1172
    View in Article

    • Google Scholar
82. • Cromer B.A.
    • Scholes D.
    • Berenson A.
    • Cundy T.
    • Clark M.K.
    • Kaunitz A.M.
    Depot medroxyprogesterone acetate and bone mineral density in adolescents-the black box warning: a position paper of the Society for Adolescent Medicine.
    J Adolesc Health. 2006; 39: 296-301
    View in Article

    • Google Scholar
83. • American College of Obstetricians and Gynecologists
    ACOG Practice Bulletin No. 73: Use of hormonal contraception in women with coexisting medical conditions.
    Obstet Gynecol. 2006; 107: 1453-1472
    View in Article

    • Google Scholar